$3,000 Invested in These Coronavirus Stocks Could Pay Off Big Time

Keith Speights, The Motley Fool
$3,000 Invested in These Coronavirus Stocks Could Pay Off Big Time

First things first: Not every company involved in developing diagnostic tests, treatments, or vaccines for COVID-19 will be a winner over the long term. After reviewing the quite lengthy list of companies with COVID-19 programs, I selected three that I think have really good chances of delivering strong returns over the next five years. Goldman Sachs recently downgraded Abbott Labs (NYSE: ABT) to a sell.